12:00 AM
 | 
Jan 16, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Pacira sales and marketing update

In April, Pacira will launch Exparel in the U.S. to treat post-operative pain. FDA approved the bupivacaine liposome extended-release injectable suspension using Pacira's DepoFoam drug delivery technology...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >